In Vivo and In Vitro Assessment of Vancomycin-Induced Nephrotoxicity
Vancomycin (VAN), a glycopeptide antibiotic introduced into clinical use in 1956, is effective against a variety of gram-positive organisms but has been associated with renal impairment in a small proportion of patients. Farber and Moellering (1983) estimated that 5% of patients treated with VAN alone exhibited signs of renal impairment whereas 35% of patients receiving VAN concurrently with an aminoglycoside were so affected, suggesting that these antibiotics may act synergistically in producing renal dysfunction. In a report of 50 patients, Sorrell and Collignon (1985) described four with renal dysfunction who received concomitant therapy with VAN and an aminoglycoside for at least 4 days. Twenty-four patients treated with VAN in combination with an aminoglycoside and 12 patients treated with VAN alone showed no signs of renal dysfunction.
KeywordsKidney Weight Glycopeptide Antibiotic Nephrotoxic Potential Proximal Tubular Dysfunction Blood Urea Nitrogen Concentration
Unable to display preview. Download preview PDF.
- Arnoff GR, Sloan RS, Dinwiddie CB Jr, Giant MD, Fineberg NS, Luft FC (1981) Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother 19:306–308Google Scholar
- Humes HD, Weinberg JM (1986) Toxic nephropathies. In: Brenner BM, Rector FC Jr (eds) The kidney, 3rd Ed, vol. II. Saunders, Philadelphia, pp 1491–1532.Google Scholar
- Humes HD, Weinberg JM, Knauss TC (1982) Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity. Am J Kidney Dis 11:5–29Google Scholar
- SAS Institute (1982) SAS user’s guide: statistics, 1982 Edn. NC/SAS Institute, CaryGoogle Scholar